News

Criteria to identify appropriate candidates for CRT and CRT-D are based ... time and effort may be spent on coronary sinus cannulation and left ventricular lead placement. Conscious sedation ...
EBR designed its WiSE system to significantly expand the population of patients who could benefit from CRT. The leadless ...
The identification of appropriate end points for cardiac resynchronization therapy devices ... an epicardial lead for LV pacing, a completely transvenous coronary sinus lead is now being used ...
Tim Boreham sharpens his knifes to look under the hood at cardiac pacing device innovator EBR Systems after its US FDA ...
Empowering Physicians, Powering Hearts. "We're delighted for the heart failure patients who were not treatable with existing CRT lead-based devices," said John McCutcheon, President and CEO of EBR ...
The US FDA has approved EBR System's leadless pacemaker WISE, the only heart device able to deliver left-ventricle stimulation.
Also known as “cardiac resynchronization therapy ... right ventricular lead for right ventricular pacing. The left ventricular lead is inserted through the coronary sinus in the right ...